cardioКардиологияKardiologiia0022-90402412-5660Kardiomag10.18087/cardio.2024.7.n2637cardio-2637Research ArticleМНЕНИЕ ЭКСПЕРТОВOPINION OF EXPERTSМетодология оценки функционального резерва и переносимости физической нагрузки при проведении клинических исследований у пациентов с ХСН (согласительный документ редколлегии журнала «Кардиология», Правления ОССН и Рабочей группы ОССН «Немедикаментозные методы лечения»)Evaluation of the Functional Reserve and Exercise Tolerance in Patients with CHF in Clinical Trials (Consent Document of the Editorial Board of the journal "Kardiologiia", the Board of the Society of Specialists in Heart Failure (SSHF) and Working Group “Non-drug treatment methods” of SSHF)https://orcid.org/0000-0001-7992-6081БеграмбековаЮ. Л.BegrambekovaYu. L.

к.м.н. ведущий научный сотрудник отдела Возраст-ассоциированных заболеваний МНОЦ МГУ имени М.В. Ломоносова

Москва, Россия

Ph.D. Leading Researcher, Department of Age-Associated Diseases, Medical Research and Educational Center of Moscow State University named after M.V. Lomonosov

Moscow, Russia

 

julia.begrambekova@ossn.ruhttps://orcid.org/0000-0002-6645-2515АрутюновГ. П.ArutynovG. P.

чл.-корр. РАН, д.м.н., профессор, зав. кафедрой пропедевтики внутренних болезней педиатрического факультета

Москва, Россия

Head of the Department of Propaedeutics of Internal Diseases of the Pension Fund,

Moscow, Russia

arut@ossn.ruhttps://orcid.org/0000-0002-0995-1924ГлезерМ. Г.GlezerM. G.

доктор медицинских наук, профессор кафедры кардиологии функциональной и ультразвуковой диагностики, ФГАОУ ВО Первый МГМУ им И.М. Сеченова МЗ РФ (Сеченовский Университет)

Москва, Россия

MD, PhD, Professor, Chair of Cardiology, Functional Diagnostics and Ultrasound Diagnostics, Institute of Clinical Medicine

Moscow, Russia

287ast@mail.ruКаранадзеH. А.KaranadzeN. A.

к.м.н. , научный сотрудник отдела Возраст-ассоциированных заболеваний МНОЦ МГУ имени М.В. Ломоносова

Москва, Россия

Researcher, Department of Age-Associated Diseases, Medical Research and Educational Center of Moscow State University named after M.V. Lomonosov

Moscow, Russia

dr.karanadze@gmail.comКолесниковаЕ. А.KolesnikovaE. A.

к.м.н., доцент кафедры пропедевтики внутренних болезней педиатрического факультета РНИМУ

Москва, Россия

associate Professor of the Department of propaedeutics of internal diseases of the faculty of Pediatrics

Moscow, Russia

e_kolesnikova@inbox.ruЛелявинаТ. А.LelyavinaT. A.

Ведущий научный сотрудник НИО микроциркуляции и метаболизма миокарда

Санкт-Петербург,  Россия

Ph.D. Leading Researcher, Almazov National Medical Research Centre

St. Petersburg, Russia

tatianalelyavina@mail.ruhttps://orcid.org/0000-0003-3391-0193ЛишутаА. С.LishutaA. S.

к.м.н., профессор кафедры госпитальной терапии №1 ИКМ им. Н.В. Склифосовского

Москва, Россия

PhD, professor at the department of Hospital therapy No. 1

Moscow, Russia

alexeylish@gmail.comhttps://orcid.org/0000-0002-8160-5612ОрловаЯ. А.OrlovaYa. A.

д.м.н., Руководитель отдела Возраст-ассоциированных заболеваний

Москва, Россия

Head of the Department of Age-Associated Diseases Medical Research Center of Moscow State University M.V. Lomonosova

Moscow, Russia

5163002@bk.ruhttps://orcid.org/0000-0002-3014-6129БеленковЮ. Н.BelenkovYu. N.

академик РАН, д.м.н., профессор, зав. кафедрой госпитальной терапии №1, Сеченовский Университет

Москва, Россия

Academician of the Russian Academy of Sciences, MD, PhD, Professor, Head of Chair of Hospital Therapy №1, Sechenov University

Moscow, Russia

ynbelenkov@gmail.com«Медицинский научно-образовательный центр» ФГБОУ ВО «Московский государственный университет им. М. В. Ломоносова»РоссияMedical Research and Educational Center, Lomonosov Moscow State UniversityRussian FederationФГАОУ ВО «РНИМУ им. Н.И. Пирогова» Минздрава РФРоссияPirogov Russian National Research Medical UniversityRussian FederationГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского» (МОНИКИ); ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава РФ (Сеченовский Университет)РоссияVladimirsky Moscow Regional Research Clinical Institute; Sechenov First Moscow State Medical UniversityRussian FederationФГБУ «Национальный медицинский исследовательский центр имени В.А. Алмазова» Минздрава РФРоссияAlmazov National Medical Research CenterRussian FederationФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава РФ (Сеченовский Университет)РоссияSechenov First Moscow State Medical UniversityRussian FederationФГАОУ ВО «Первый МГМУ имени И.М. Сеченова Минздрава РФ (Сеченовский Университет)»РоссияSechenov First Moscow State Medical UniversityRussian Federation202431072024647426Copyright © Kardiomag, 20242024KardiomagKardiomaghttps://cardio.elpub.ru/jour/about/submissions#copyrightNoticehttps://cardio.elpub.ru/jour/article/view/2637

Оценка функциональной способности и толерантности к физической нагрузке является важным и широко используемым исследовательским инструментом у пациентов с сердечной недостаточностью и применяется не только в контексте кардиореабилитации и физических методов лечения пациентов, но и в качестве критериев включения и оценки исходов при проведении исследований медикаментозных вмешательств. В документе изложены область применения, рекомендации по выполнению и интерпретации, а также ограничения методов оценки функциональной способности и толерантности к физической нагрузке при проведении клинических исследований у пациентов с сердечной недостаточностью.

Assessing the functional capacity and exercise tolerance is an important and widely used research tool in patients with heart failure. It is used not only in cardiac rehabilitation and physical therapy, but also for inclusion criteria and outcome measures in studies of drug interventions. This document outlines the scope, guidelines for the implementation and interpretation, and limitations of the methods for assessing the functional capacity and exercise tolerance in clinical trials in patients with heart failure.

Сердечная недостаточностьфизические нагрузкимиопатия сердечной недостаточностиэргорефлекскардиореспираторная выносливостькардиореспираторное нагрузочное тестированиеФК6МТХсила дыхательной мускулатурыодноповторный максимумHeart failureexercisehear failure myopathyergoreflexcardiorespiratory endurancecardiopulmonary stress testFC6MWTrespiratory muscle strengthone-repetition maximumКонфликт интересов не заявленNo conflict of interest is reported.ReferencesNomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. P. 253-256. Dolgin M, New York Heart Association, editors - Boston, Mass.: Little, Brown and Co, 1994. – 334p. ISBN 978-0-316-60538-0Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. P. 253-256. Dolgin M, New York Heart Association, editors - Boston, Mass.: Little, Brown and Co, 1994. – 334p. ISBN 978-0-316-60538-0Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64(6):1227–34. DOI: 10.1161/01.CIR.64.6.1227Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64(6):1227–34. DOI: 10.1161/01.CIR.64.6.1227Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007;93(4):476–82. DOI: 10.1136/hrt.2006.089656Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007;93(4):476–82. DOI: 10.1136/hrt.2006.089656Yap J, Lim FY, Gao F, Teo LL, Lam CSP, Yeo KK. Correlation of the New York Heart Association Classification and the 6‐Minute Walk Distance: A Systematic Review. Clinical Cardiology. 2015;38(10):621–8. DOI: 10.1002/clc.22468Yap J, Lim FY, Gao F, Teo LL, Lam CSP, Yeo KK. Correlation of the New York Heart Association Classification and the 6‐Minute Walk Distance: A Systematic Review. Clinical Cardiology. 2015;38(10):621–8. DOI: 10.1002/clc.22468Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two- , six-, and 12-minute walking tests in respiratory disease. BMJ. 1982;284(6329):1607–8. DOI: 10.1136/bmj.284.6329.1607Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two- , six-, and 12-minute walking tests in respiratory disease. BMJ. 1982;284(6329):1607–8. DOI: 10.1136/bmj.284.6329.1607Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Canadian Medical Association Journal. 1985;132(8):919–23. PMID: 3978515Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Canadian Medical Association Journal. 1985;132(8):919–23. PMID: 3978515Fuentes-Abolafio IJ, Stubbs B, Pérez-Belmonte LM, Bernal-López MR, Gómez-Huelgas R, Cuesta-Vargas AI. Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis. BMC Cardiovascular Disorders. 2020;20(1):512. DOI: 10.1186/s12872-020-01725-5Fuentes-Abolafio IJ, Stubbs B, Pérez-Belmonte LM, Bernal-López MR, Gómez-Huelgas R, Cuesta-Vargas AI. Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis. BMC Cardiovascular Disorders. 2020;20(1):512. DOI: 10.1186/s12872-020-01725-5Hanson LC, McBurney H, Taylor NF. The retest reliability of the six‐minute walk test in patients referred to a cardiac rehabilitation programme. Physiotherapy Research International. 2012;17(1):55–61. DOI: 10.1002/pri.513Hanson LC, McBurney H, Taylor NF. The retest reliability of the six‐minute walk test in patients referred to a cardiac rehabilitation programme. Physiotherapy Research International. 2012;17(1):55–61. DOI: 10.1002/pri.513Wu G, Sanderson B, Bittner V. The 6-minute walk test: How important is the learning effect? American Heart Journal. 2003;146(1):129–33. DOI: 10.1016/S0002-8703(03)00119-4Wu G, Sanderson B, Bittner V. The 6-minute walk test: How important is the learning effect? American Heart Journal. 2003;146(1):129–33. DOI: 10.1016/S0002-8703(03)00119-4Hamilton DM, Haennel RG. Validity and Reliability of the 6-Minute Walk Test in a Cardiac Rehabilitation Population. Journal of Cardiopulmonary Rehabilitation. 2000;20(3):156–64. DOI: 10.1097/00008483200005000-00003Hamilton DM, Haennel RG. Validity and Reliability of the 6-Minute Walk Test in a Cardiac Rehabilitation Population. Journal of Cardiopulmonary Rehabilitation. 2000;20(3):156–64. DOI: 10.1097/00008483200005000-00003Lans C, Cider Å, Nylander E, Brudin L. Test–retest reliability of six‐minute walk tests over a one‐year period in patients with chronic heart failure. Clinical Physiology and Functional Imaging. 2020;40(4):284–9. DOI: 10.1111/cpf.12637Lans C, Cider Å, Nylander E, Brudin L. Test–retest reliability of six‐minute walk tests over a one‐year period in patients with chronic heart failure. Clinical Physiology and Functional Imaging. 2020;40(4):284–9. DOI: 10.1111/cpf.12637Ситникова М.Ю., Лелявина Т.А., Шляхто Е.В., Иванов С.Г., Трукшина М.А., Федотов П.А. и др. Эффективность и прогностическая ценность методов диагностики тяжести хронической сердечной недостаточности у пациентов разного возраста. Артериальная гипертензия. 2008;14(S1-2):5–11Sitnikova M.Yu., Lelyavina T.A., Shlyakhto E.V., Ivanov S.G., Trukshina M.A., Fedotov P.A. et al. Effectiveness and prognostic value of diagnostic methods for the severity of chronic heart failure in patients of different ages. Arterial Hypertension. 2008;14(S1-2):5–11.Терещенко С.Н. Галявич А.С., Ускач Т.М., Агеев Ф.Т., Арутюнов Г.П., Беграмбекова Ю.Л. и др. Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):311-74. DOI: 10.15829/1560-4071-2020-4083Tereshchenko S.N., Galyavich A.S., Uskach T.M., Ageev F.T., Arutyunov G.P., Begrambekova Yu.L. et al. 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):311–74. DOI: 10.15829/1560-4071-2020-4083ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: Guidelines for the Six-Minute Walk Test. American Journal of Respiratory and Critical Care Medicine. 2002;166(1):111–7. DOI: 10.1164/ajrccm.166.1.at1102ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: Guidelines for the Six-Minute Walk Test. American Journal of Respiratory and Critical Care Medicine. 2002;166(1):111–7. DOI: 10.1164/ajrccm.166.1.at1102Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology. 2022;79(17):e263–421. DOI: 10.1016/j.jacc.2021.12.012Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology. 2022;79(17):e263–421. DOI: 10.1016/j.jacc.2021.12.012Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF et al. Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults: A Scientific Statement From the American Heart Association. Circulation. 2010;122(2):191–225. DOI: 10.1161/CIR.0b013e3181e52e69Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF et al. Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults: A Scientific Statement From the American Heart Association. Circulation. 2010;122(2):191–225. DOI: 10.1161/CIR.0b013e3181e52e69Арутюнов Г.П., Колесникова Е.А., Беграмбекова Ю.Л., Орлова Я.А., Рылова А.К., Аронов Д.М. и др. Рекомендации по назначению физических тренировок пациентам с хронической сердечной недостаточностью. Журнал Сердечная Недостаточность. 2017;18(1):41–66. DOI: 10.18087/rhfj.2017.1.2339Arutyunov G.P., Kolesnikova E.A., Begrambekova Yu.L., Orlova Ya.A., Rylova A.K., Aronov D.M. et al. Exercise training in chronic heart failure: practical guidance of the Russian Heart Failure Society. Russian Heart Failure Journal. 2017;18(1):41–66. DOI: 10.18087/rhfj.2017.1.2339American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on Cardiopulmonary Exercise Testing. American Journal of Respiratory and Critical Care Medicine. 2003;167(2):211–77. DOI: 10.1164/rccm.167.2.211American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on Cardiopulmonary Exercise Testing. American Journal of Respiratory and Critical Care Medicine. 2003;167(2):211–77. DOI: 10.1164/rccm.167.2.211Balke B, Ware RW. An experimental study of physical fitness of Air Force personnel. United States Armed Forces Medical Journal. 1959;10(6):675–88. PMID: 13659732Balke B, Ware RW. An experimental study of physical fitness of Air Force personnel. United States Armed Forces Medical Journal. 1959;10(6):675–88. PMID: 13659732Myers J, Bellin D. Ramp Exercise Protocols for Clinical and Cardiopulmonary Exercise Testing. Sports Medicine. 2000;30(1):23–9. DOI: 10.2165/00007256-200030010-00003Myers J, Bellin D. Ramp Exercise Protocols for Clinical and Cardiopulmonary Exercise Testing. Sports Medicine. 2000;30(1):23–9. DOI: 10.2165/00007256-200030010-00003Agostoni P, Bianchi M, Moraschi A, Palermo P, Cattadori G, La Gioia R и др. Work-rate affects cardiopulmonary exercise test results in heart failure. European Journal of Heart Failure. 2005;7(4):498–504. DOI: 10.1016/j.ejheart.2004.06.007Agostoni P, Bianchi M, Moraschi A, Palermo P, Cattadori G, La Gioia R и др. Work-rate affects cardiopulmonary exercise test results in heart failure. European Journal of Heart Failure. 2005;7(4):498–504. DOI: 10.1016/j.ejheart.2004.06.007Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ. Optimizing the exercise protocol for cardiopulmonary assessment. Journal of Applied Physiology. 1983;55(5):1558–64. DOI: 10.1152/jappl.1983.55.5.1558Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ. Optimizing the exercise protocol for cardiopulmonary assessment. Journal of Applied Physiology. 1983;55(5):1558–64. DOI: 10.1152/jappl.1983.55.5.1558Lala A, Shah KB, Lanfear DE, Thibodeau JT, Palardy M, Ambardekar AV et al. Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart Failure. JACC: Heart Failure. 2021;9(3):226–36. DOI: 10.1016/j.jchf.2020.11.008Lala A, Shah KB, Lanfear DE, Thibodeau JT, Palardy M, Ambardekar AV et al. Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart Failure. JACC: Heart Failure. 2021;9(3):226–36. DOI: 10.1016/j.jchf.2020.11.008Ingle L, Witte KK, Cleland JGJF, Clark AL. The prognostic value of cardiopulmonary exercise testing with a peak respiratory exchange ratio of <1.0 in patients with chronic heart failure. International Journal of Cardiology. 2008;127(1):88–92. DOI: 10.1016/j.ijcard.2007.04.075Ingle L, Witte KK, Cleland JGJF, Clark AL. The prognostic value of cardiopulmonary exercise testing with a peak respiratory exchange ratio of <1.0 in patients with chronic heart failure. International Journal of Cardiology. 2008;127(1):88–92. DOI: 10.1016/j.ijcard.2007.04.075Каранадзе Н.А., Беграмбекова Ю.Л., Борисов Е.Н., Орлова Я.А. Ширина распределения эритроцитов как предиктор низкой толерантности к физической нагрузке у пациентов с хронической сердечной недостаточностью. Кардиология. 2022;62(4):30-5. DOI: 10.18087/cardio.2022.4.n1813Karanadze N.A., Begrambekova Yu.L., Borisov E.N., Orlova Ya.A. Red cell distribution width as a predictor of impaired exercise capacity in patients with heart failure. Kardiologiia. 2022;62(4):30–5. DOI: 10.18087/cardio.2022.4.n1813Ozemek C, Arena R. Cardiopulmonary Exercise Testing in Patients With Heart Failure and a Preserved Ejection Fraction: Filling the Prognostic Knowledge Gap. Revista Española de Cardiología (English Edition). 2018;71(4):237–9. DOI: 10.1016/j.rec.2017.08.012Ozemek C, Arena R. Cardiopulmonary Exercise Testing in Patients With Heart Failure and a Preserved Ejection Fraction: Filling the Prognostic Knowledge Gap. Revista Española de Cardiología (English Edition). 2018;71(4):237–9. DOI: 10.1016/j.rec.2017.08.012Zugck C, Haunstetter A, Krüger C, Kell R, Schellberg D, Kübler W и др. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. Journal of the American College of Cardiology. 2002;39(10):1615–22. DOI: 10.1016/S0735-1097(02)01840-5Zugck C, Haunstetter A, Krüger C, Kell R, Schellberg D, Kübler W и др. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. Journal of the American College of Cardiology. 2002;39(10):1615–22. DOI: 10.1016/S0735-1097(02)01840-5Guimaraes GV, d’Avila VM, Silva MS, Ferreira SA, Ciolac EG, Carvalho VO et al. A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with beta-blocker therapy. International Journal of Cardiology. 2010;145(1):75–7. DOI: 10.1016/j.ijcard.2009.05.001Guimaraes GV, d’Avila VM, Silva MS, Ferreira SA, Ciolac EG, Carvalho VO et al. A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with beta-blocker therapy. International Journal of Cardiology. 2010;145(1):75–7. DOI: 10.1016/j.ijcard.2009.05.001O’Neill JO, Young JB, Pothier CE, Lauer MS. Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-Blockers. Circulation. 2005;111(18):2313–8. DOI: 10.1161/01.CIR.0000164270.72123.18O’Neill JO, Young JB, Pothier CE, Lauer MS. Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-Blockers. Circulation. 2005;111(18):2313–8. DOI: 10.1161/01.CIR.0000164270.72123.18Sarullo FM, Fazio G, Brusca I, Fasullo S, Paterna S, Licata P et al. Cardiopulmonary Exercise Testing in Patients with Chronic Heart Failure: Prognostic Comparison from Peak VO2 and VE/VCO2 Slope. The Open Cardiovascular Medicine Journal. 2010;4(1):127–34. DOI: 10.2174/1874192401004010127Sarullo FM, Fazio G, Brusca I, Fasullo S, Paterna S, Licata P et al. Cardiopulmonary Exercise Testing in Patients with Chronic Heart Failure: Prognostic Comparison from Peak VO2 and VE/VCO2 Slope. The Open Cardiovascular Medicine Journal. 2010;4(1):127–34. DOI: 10.2174/1874192401004010127Corrà U, Giordano A, Piepoli M. Cardiopulmonary exercise testing in chronic heart failure patients treated with beta-blockers: Still a valid prognostic tool. International Journal of Cardiology. 2020;317:128–32. DOI: 10.1016/j.ijcard.2020.04.020Corrà U, Giordano A, Piepoli M. Cardiopulmonary exercise testing in chronic heart failure patients treated with beta-blockers: Still a valid prognostic tool. International Journal of Cardiology. 2020;317:128–32. DOI: 10.1016/j.ijcard.2020.04.020Swank AM, Horton J, Fleg JL, Fonarow GC, Keteyian S, Goldberg L и др. Modest Increase in Peak VO2 Is Related to Better Clinical Outcomes in Chronic Heart Failure Patients: Results From Heart Failure and a Controlled Trial to Investigate Outcomes of Exercise Training. Circulation: Heart Failure. 2012;5(5):579–85. DOI: 10.1161/CIRCHEARTFAILURE.111.965186Swank AM, Horton J, Fleg JL, Fonarow GC, Keteyian S, Goldberg L и др. Modest Increase in Peak VO2 Is Related to Better Clinical Outcomes in Chronic Heart Failure Patients: Results From Heart Failure and a Controlled Trial to Investigate Outcomes of Exercise Training. Circulation: Heart Failure. 2012;5(5):579–85. DOI: 10.1161/CIRCHEARTFAILURE.111.965186Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. Journal of the American College of Cardiology. 2011;58(3):265–74. DOI: 10.1016/j.jacc.2011.02.055Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. Journal of the American College of Cardiology. 2011;58(3):265–74. DOI: 10.1016/j.jacc.2011.02.055Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation. 1982;65(6):1213–23. DOI: 10.1161/01.CIR.65.6.1213Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation. 1982;65(6):1213–23. DOI: 10.1161/01.CIR.65.6.1213Guazzi M, Borlaug B, Metra M, Losito M, Bandera F, Alfonzetti E et al. Revisiting and Implementing the Weber and Ventilatory Functional Classifications in Heart Failure by Cardiopulmonary Imaging Phenotyping. Journal of the American Heart Association. 2021;10(5):e018822. DOI: 10.1161/ JAHA.120.018822Guazzi M, Borlaug B, Metra M, Losito M, Bandera F, Alfonzetti E et al. Revisiting and Implementing the Weber and Ventilatory Functional Classifications in Heart Failure by Cardiopulmonary Imaging Phenotyping. Journal of the American Heart Association. 2021;10(5):e018822. DOI: 10.1161/ JAHA.120.018822Jaussaud J, Blanc P, Derval N, Bordachar P, Courregelongue M, Roudaut R et al. Ventilatory response and peak circulatory power: New functional markers of response after cardiac resynchronization therapy. Archives of Cardiovascular Diseases. 2010;103(3):184–91. DOI: 10.1016/j.acvd.2010.01.003Jaussaud J, Blanc P, Derval N, Bordachar P, Courregelongue M, Roudaut R et al. Ventilatory response and peak circulatory power: New functional markers of response after cardiac resynchronization therapy. Archives of Cardiovascular Diseases. 2010;103(3):184–91. DOI: 10.1016/j.acvd.2010.01.003Cohen-Solal A. A non-invasively determined surrogate of cardiac power (‘circulatory power’) at peak exercise is a powerful prognostic factor in chronic heart failure. European Heart Journal. 2002;23(10):806–14. DOI: 10.1053/euhj.2001.2966Cohen-Solal A. A non-invasively determined surrogate of cardiac power (‘circulatory power’) at peak exercise is a powerful prognostic factor in chronic heart failure. European Heart Journal. 2002;23(10):806–14. DOI: 10.1053/euhj.2001.2966Giardini A, Specchia S, Berton E, Sangiorgi D, Coutsoumbas G, Gargiulo G et al. Strong and independent prognostic value of peak circulatory power in adults with congenital heart disease. American Heart Journal. 2007;154(3):441–7. DOI: 10.1016/j.ahj.2007.05.009Giardini A, Specchia S, Berton E, Sangiorgi D, Coutsoumbas G, Gargiulo G et al. Strong and independent prognostic value of peak circulatory power in adults with congenital heart disease. American Heart Journal. 2007;154(3):441–7. DOI: 10.1016/j.ahj.2007.05.009Madan N, Beachler L, Konstantinopoulos P, Worley S, Sun Z, Latson LA. Peak Circulatory Power as an Indicator of Clinical Status in Children After Fontan Procedure. Pediatric Cardiology. 2010;31(8):1203–8. DOI: 10.1007/s00246-010-9799-1Madan N, Beachler L, Konstantinopoulos P, Worley S, Sun Z, Latson LA. Peak Circulatory Power as an Indicator of Clinical Status in Children After Fontan Procedure. Pediatric Cardiology. 2010;31(8):1203–8. DOI: 10.1007/s00246-010-9799-1Methvin AB, Owens AT, Emmi AG, Allen M, Wiegers SE, Dries DL et al. Ventilatory Inefficiency Reflects Right Ventricular Dysfunction in Systolic Heart Failure. Chest. 2011;139(3):617–25. DOI: 10.1378/chest.10-0318Methvin AB, Owens AT, Emmi AG, Allen M, Wiegers SE, Dries DL et al. Ventilatory Inefficiency Reflects Right Ventricular Dysfunction in Systolic Heart Failure. Chest. 2011;139(3):617–25. DOI: 10.1378/chest.10-0318Nayor M, Xanthakis V, Tanguay M, Blodgett JB, Shah RV, Schoenike M et al. Clinical and Hemodynamic Associations and Prognostic Implications of Ventilatory Efficiency in Patients With Preserved Left Ventricular Systolic Function. Circulation: Heart Failure. 2020;13(5):e006729. DOI: 10.1161/CIRCHEARTFAILURE.119.006729Nayor M, Xanthakis V, Tanguay M, Blodgett JB, Shah RV, Schoenike M et al. Clinical and Hemodynamic Associations and Prognostic Implications of Ventilatory Efficiency in Patients With Preserved Left Ventricular Systolic Function. Circulation: Heart Failure. 2020;13(5):e006729. DOI: 10.1161/CIRCHEARTFAILURE.119.006729Lewis GD, Shah RV, Pappagianopolas PP, Systrom DM, Semigran MJ. Determinants of Ventilatory Efficiency in Heart Failure: The Role of Right Ventricular Performance and Pulmonary Vascular Tone. Circulation: Heart Failure. 2008;1(4):227–33. DOI: 10.1161/CIRCHEARTFAILURE.108.785501Lewis GD, Shah RV, Pappagianopolas PP, Systrom DM, Semigran MJ. Determinants of Ventilatory Efficiency in Heart Failure: The Role of Right Ventricular Performance and Pulmonary Vascular Tone. Circulation: Heart Failure. 2008;1(4):227–33. DOI: 10.1161/CIRCHEARTFAILURE.108.785501Cahalin LP, Chase P, Arena R, Myers J, Bensimhon D, Peberdy MA et al. A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure. Heart Failure Reviews. 2013;18(1):79–94. DOI: 10.1007/s10741-012-9332-0Cahalin LP, Chase P, Arena R, Myers J, Bensimhon D, Peberdy MA et al. A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure. Heart Failure Reviews. 2013;18(1):79–94. DOI: 10.1007/s10741-012-9332-0Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P et al. Development of a Ventilatory Classification System in Patients With Heart Failure. Circulation. 2007;115(18):2410–7. DOI: 10.1161/CIRCULATIONAHA.107.686576Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P et al. Development of a Ventilatory Classification System in Patients With Heart Failure. Circulation. 2007;115(18):2410–7. DOI: 10.1161/CIRCULATIONAHA.107.686576Hollenberg M, Tager IB. Oxygen uptake efficiency slope: an index of exercise performance and cardiopulmonary reserve requiring only submaximal exercise. Journal of the American College of Cardiology. 2000;36(1):194–201. DOI: 10.1016/S0735-1097(00)00691-4Hollenberg M, Tager IB. Oxygen uptake efficiency slope: an index of exercise performance and cardiopulmonary reserve requiring only submaximal exercise. Journal of the American College of Cardiology. 2000;36(1):194–201. DOI: 10.1016/S0735-1097(00)00691-4Forman DE, Guazzi M, Myers J, Chase P, Bensimhon D, Cahalin LP et al. Ventilatory Power: A Novel Index That Enhances Prognostic Assessment of Patients With Heart Failure. Circulation: Heart Failure. 2012;5(5):621–6. DOI: 10.1161/CIRCHEARTFAILURE.112.968529Forman DE, Guazzi M, Myers J, Chase P, Bensimhon D, Cahalin LP et al. Ventilatory Power: A Novel Index That Enhances Prognostic Assessment of Patients With Heart Failure. Circulation: Heart Failure. 2012;5(5):621–6. DOI: 10.1161/CIRCHEARTFAILURE.112.968529Castello-Simões V, Minatel V, Karsten M, Simões RP, Perseguini NM, Milan JC et al. Circulatory and Ventilatory Power: Characterization in Patients with Coronary Artery Disease. Arquivos Brasileiros de Cardiologia. 2015;104(6):476–85. DOI: 10.5935/abc.20150035Castello-Simões V, Minatel V, Karsten M, Simões RP, Perseguini NM, Milan JC et al. Circulatory and Ventilatory Power: Characterization in Patients with Coronary Artery Disease. Arquivos Brasileiros de Cardiologia. 2015;104(6):476–85. DOI: 10.5935/abc.20150035Gitt AK, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M et al. Exercise Anaerobic Threshold and Ventilatory Efficiency Identify Heart Failure Patients for High Risk of Early Death. Circulation. 2002;106(24):3079–84. DOI: 10.1161/01.CIR.0000041428.99427.06Gitt AK, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M et al. Exercise Anaerobic Threshold and Ventilatory Efficiency Identify Heart Failure Patients for High Risk of Early Death. Circulation. 2002;106(24):3079–84. DOI: 10.1161/01.CIR.0000041428.99427.06Corrà U, Giordano A, Mezzani A, Gnemmi M, Pistono M, Caruso R et al. Cardiopulmonary exercise testing and prognosis in heart failure due to systolic left ventricular dysfunction: a validation study of the European Society of Cardiology Guidelines and Recommendations (2008) and further developments. European Journal of Preventive Cardiology. 2012;19(1):32–40. DOI: 10.1177/1741826710393994Corrà U, Giordano A, Mezzani A, Gnemmi M, Pistono M, Caruso R et al. Cardiopulmonary exercise testing and prognosis in heart failure due to systolic left ventricular dysfunction: a validation study of the European Society of Cardiology Guidelines and Recommendations (2008) and further developments. European Journal of Preventive Cardiology. 2012;19(1):32–40. DOI: 10.1177/1741826710393994Agostoni P, Corrà U, Cattadori G, Veglia F, Battaia E, La Gioia R et al. Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. Circulation: Heart Failure. 2013;6(5):977–87. DOI: 10.1161/CIRCHEARTFAILURE.113.000471Agostoni P, Corrà U, Cattadori G, Veglia F, Battaia E, La Gioia R et al. Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. Circulation: Heart Failure. 2013;6(5):977–87. DOI: 10.1161/CIRCHEARTFAILURE.113.000471Corrà U, Pistono M, Mezzani A, Braghiroli A, Giordano A, Lanfranchi P и др. Sleep and Exertional Periodic Breathing in Chronic Heart Failure: Prognostic Importance and Interdependence. Circulation. 2006;113(1):44–50. DOI: 10.1161/CIRCULATIONAHA.105.543173Corrà U, Pistono M, Mezzani A, Braghiroli A, Giordano A, Lanfranchi P и др. Sleep and Exertional Periodic Breathing in Chronic Heart Failure: Prognostic Importance and Interdependence. Circulation. 2006;113(1):44–50. DOI: 10.1161/CIRCULATIONAHA.105.543173Guazzi M, Arena R, Ascione A, Piepoli M, Guazzi MD. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: An unfavorable combination with high prognostic value. American Heart Journal. 2007;153(5):859–67. DOI: 10.1016/j.ahj.2007.02.034Guazzi M, Arena R, Ascione A, Piepoli M, Guazzi MD. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: An unfavorable combination with high prognostic value. American Heart Journal. 2007;153(5):859–67. DOI: 10.1016/j.ahj.2007.02.034Laoutaris ID, Piotrowicz E, Kallistratos MS, Dritsas A, Dimaki N, Miliopoulos D et al. Combined aerobic/resistance/inspiratory muscle training as the ‘optimum’ exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial. European Journal of Preventive Cardiology. 2021;28(15):1626–35. DOI: 10.1093/eurjpc/zwaa091Laoutaris ID, Piotrowicz E, Kallistratos MS, Dritsas A, Dimaki N, Miliopoulos D et al. Combined aerobic/resistance/inspiratory muscle training as the ‘optimum’ exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial. European Journal of Preventive Cardiology. 2021;28(15):1626–35. DOI: 10.1093/eurjpc/zwaa091Barron A, Dhutia N, Mayet J, Hughes AD, Francis DP, Wensel R. Test–retest repeatability of cardiopulmonary exercise test variables in patients with cardiac or respiratory disease. European Journal of Preventive Cardiology. 2014;21(4):445–53. DOI: 10.1177/2047487313518474Barron A, Dhutia N, Mayet J, Hughes AD, Francis DP, Wensel R. Test–retest repeatability of cardiopulmonary exercise test variables in patients with cardiac or respiratory disease. European Journal of Preventive Cardiology. 2014;21(4):445–53. DOI: 10.1177/2047487313518474Беграмбекова Ю.Л., Федотов Д.А., Каранадзе Н.А., Лелявина Т.А., Борцова М.А., Орлова Я.А. Возможности прогнозирования пикового потребления кислорода у пациентов с хронической сердечной недостаточностью по данным 6-минутного теста ходьбы. Кардиология. 2024;64(2):34-42. DOI: 10.18087/cardio.2024.2.n2551Begrambekova Yu.L., Fedotov D.A., Karanadze N.A., Lelyavina T.A., Bortsova M.A., Orlova Ya.A. Possibilities of Predicting Peak Oxygen Consumption in Patients With Chronic Heart Failure According to the 6-Minute Walk Test. Kardiologiia. 2024;64(2):34–42. DOI: 10.18087/cardio.2024.2.n2551Burr JF, Bredin SSD, Faktor MD, Warburton DER. The 6-Minute Walk Test as a Predictor of Objectively Measured Aerobic Fitness in Healthy WorkingAged Adults. The Physician and Sportsmedicine. 2011;39(2):133–9. DOI: 10.3810/psm.2011.05.1904Burr JF, Bredin SSD, Faktor MD, Warburton DER. The 6-Minute Walk Test as a Predictor of Objectively Measured Aerobic Fitness in Healthy WorkingAged Adults. The Physician and Sportsmedicine. 2011;39(2):133–9. DOI: 10.3810/psm.2011.05.1904Ross RM, Murthy JN, Wollak ID, Jackson AS. The six minute walk test accurately estimates mean peak oxygen uptake. BMC Pulmonary Medicine. 2010;10(1):31. DOI: 10.1186/1471-2466-10-31Ross RM, Murthy JN, Wollak ID, Jackson AS. The six minute walk test accurately estimates mean peak oxygen uptake. BMC Pulmonary Medicine. 2010;10(1):31. DOI: 10.1186/1471-2466-10-31Adedoyin RA, Adeyanju SA, Balogun MO, Adebayo RA, Akintomide AO, Akinwusi PO. Prediction of functional capacity during six-minute walk among patients with chronic heart failure. Nigerian Journal of Clinical Practice. 2010;13(4):379–81. PMID: 21220849Adedoyin RA, Adeyanju SA, Balogun MO, Adebayo RA, Akintomide AO, Akinwusi PO. Prediction of functional capacity during six-minute walk among patients with chronic heart failure. Nigerian Journal of Clinical Practice. 2010;13(4):379–81. PMID: 21220849Cahalin LP, Mathier MA, Semigran MJ, Dec GW, DiSalvo TG. The SixMinute Walk Test Predicts Peak Oxygen Uptake and Survival in Patients With Advanced Heart Failure. Chest. 1996;110(2):325–32. DOI: 10.1378/chest.110.2.325Cahalin LP, Mathier MA, Semigran MJ, Dec GW, DiSalvo TG. The SixMinute Walk Test Predicts Peak Oxygen Uptake and Survival in Patients With Advanced Heart Failure. Chest. 1996;110(2):325–32. DOI: 10.1378/chest.110.2.325ACSM’s guidelines for exercise testing and prescription. Pescatello LS, American College of Sports Medicine, editor - Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health, 2014. – 456p. ISBN 978-1-60913-605-5ACSM’s guidelines for exercise testing and prescription. Pescatello LS, American College of Sports Medicine, editor - Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health, 2014. – 456p. ISBN 978-1-60913-605-5Zhang Y, Zhang J, Ni W, Yuan X, Zhang H, Li P et al. Sarcopenia in heart failure: a systematic review and meta‐analysis. ESC Heart Failure. 2021;8(2):1007–17. DOI: 10.1002/ehf2.13255Zhang Y, Zhang J, Ni W, Yuan X, Zhang H, Li P et al. Sarcopenia in heart failure: a systematic review and meta‐analysis. ESC Heart Failure. 2021;8(2):1007–17. DOI: 10.1002/ehf2.13255Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N et al. Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). European Journal of Heart Failure. 2018;20(11):1580–7. DOI: 10.1002/ejhf.1304Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N et al. Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). European Journal of Heart Failure. 2018;20(11):1580–7. DOI: 10.1002/ejhf.1304Joseph GA, Wang SX, Jacobs CE, Zhou W, Kimble GC, Tse HW et al. Partial Inhibition of mTORC1 in Aged Rats Counteracts the Decline in Muscle Mass and Reverses Molecular Signaling Associated with Sarcopenia. Molecular and Cellular Biology. 2019;39(19):e00141-19. DOI: 10.1128/MCB.00141-19Joseph GA, Wang SX, Jacobs CE, Zhou W, Kimble GC, Tse HW et al. Partial Inhibition of mTORC1 in Aged Rats Counteracts the Decline in Muscle Mass and Reverses Molecular Signaling Associated with Sarcopenia. Molecular and Cellular Biology. 2019;39(19):e00141-19. DOI: 10.1128/MCB.00141-19Bossone E, Arcopinto M, Iacoviello M, Triggiani V, Cacciatore F, Maiello C et al. Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry. Internal and Emergency Medicine. 2018;13(5):661–71. DOI: 10.1007/s11739-018-1844-8Bossone E, Arcopinto M, Iacoviello M, Triggiani V, Cacciatore F, Maiello C et al. Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry. Internal and Emergency Medicine. 2018;13(5):661–71. DOI: 10.1007/s11739-018-1844-8Alam M, Smirk FH. Observations in man upon a blood pressure raising reflex arising from the voluntary muscles. The Journal of Physiology. 1937;89(4):372–83. DOI: 10.1113/jphysiol.1937.sp003485Alam M, Smirk FH. Observations in man upon a blood pressure raising reflex arising from the voluntary muscles. The Journal of Physiology.Nobrega ACL, O’Leary D, Silva BM, Marongiu E, Piepoli MF, Crisafulli A. Neural Regulation of Cardiovascular Response to Exercise: Role of Central Command and Peripheral Afferents. BioMed Research International. 2014;2014:1–20. DOI: 10.1155/2014/4789651937;89(4):372–83. DOI: 10.1113/jphysiol.1937.sp003485Crisafulli A, Marongiu E, Ogoh S. Cardiovascular Reflexes Activity and Their Interaction during Exercise. BioMed Research International. 2015;2015:1–10. DOI: 10.1155/2015/394183Nobrega ACL, O’Leary D, Silva BM, Marongiu E, Piepoli MF, Crisafulli A. Neural Regulation of Cardiovascular Response to Exercise: Role of Central Command and Peripheral Afferents. BioMed Research International. 2014;2014:1–20. DOI: 10.1155/2014/478965Scott AC, Wensel R, Davos CH, Kemp M, Kaczmarek A, Hooper J et al. Chemical Mediators of the Muscle Ergoreflex in Chronic Heart Failure: A Putative Role for Prostaglandins in Reflex Ventilatory Control. Circulation. 2002;106(2):214–20. DOI: 10.1161/01.CIR.0000021603.36744.5ECrisafulli A, Marongiu E, Ogoh S. Cardiovascular Reflexes Activity and Their Interaction during Exercise. BioMed Research International. 2015;2015:1–10. DOI: 10.1155/2015/394183Grgic J, Lazinica B, Schoenfeld BJ, Pedisic Z. Test–Retest Reliability of the One-Repetition Maximum (1RM) Strength Assessment: a Systematic Review. Sports Medicine - Open. 2020;6(1):31. DOI: 10.1186/s40798-020-00260-zScott AC, Wensel R, Davos CH, Kemp M, Kaczmarek A, Hooper J et al. Chemical Mediators of the Muscle Ergoreflex in Chronic Heart Failure: A Putative Role for Prostaglandins in Reflex Ventilatory Control. Circulation. 2002;106(2):214–20. DOI: 10.1161/01.CIR.0000021603.36744.5EPavasini R, Serenelli M, Celis-Morales CA, Gray SR, Izawa KP, Watanabe S et al. Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis. Heart. 2019;105(11):834–41. DOI: 10.1136/heartjnl-2018-313816Grgic J, Lazinica B, Schoenfeld BJ, Pedisic Z. Test–Retest Reliability of the One-Repetition Maximum (1RM) Strength Assessment: a Systematic Review. Sports Medicine - Open. 2020;6(1):31. DOI: 10.1186/s40798-020-00260-zLi R-M, Dai G-H, Guan H, Gao W-L, Ren L-L, Wang X-M et al. Association between handgrip strength and heart failure in adults aged 45 years and older from NHANES 2011–2014. Scientific Reports. 2023;13(1):4551. DOI: 10.1038/s41598-023-31578-9Pavasini R, Serenelli M, Celis-Morales CA, Gray SR, Izawa KP, Watanabe S et al. Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis. Heart. 2019;105(11):834–41. DOI: 10.1136/heartjnl-2018-313816Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG et al. A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission. Journal of Gerontology. 1994;49(2):M85–94. DOI: 10.1093/geronj/49.2.M85Li R-M, Dai G-H, Guan H, Gao W-L, Ren L-L, Wang X-M et al. Association between handgrip strength and heart failure in adults aged 45 years and older from NHANES 2011–2014. Scientific Reports. 2023;13(1):4551. DOI: 10.1038/s41598-023-31578-9Kitai T, Shimogai T, Tang WHW, Iwata K, Xanthopoulos A, Otsuka S и др. Short physical performance battery vs. 6-minute walking test in hospitalized elderly patients with heart failure. European Heart Journal Open. 2021;1(1):oeab006. DOI: 10.1093/ehjopen/oeab006Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG et al. A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission. Journal of Gerontology. 1994;49(2):M85–94. DOI: 10.1093/geronj/49.2.M85Беграмбекова Ю.Л., Каранадзе Н.А., Орлова Я.А. Нарушения системы дыхания при хронической сердечной недостаточности. Кардиология. 2019;59(2S):15-24. DOI: 10.18087/cardio.2626Kitai T, Shimogai T, Tang WHW, Iwata K, Xanthopoulos A, Otsuka S и др. Short physical performance battery vs. 6-minute walking test in hospitalized elderly patients with heart failure. European Heart Journal Open. 2021;1(1):oeab006. DOI: 10.1093/ehjopen/oeab006Hamazaki N, Kamiya K, Matsuzawa R, Nozaki K, Ichikawa T, Tanaka S et al. Prevalence and prognosis of respiratory muscle weakness in heart failure patients with preserved ejection fraction. Respiratory Medicine. 2020;161:105834. DOI: 10.1016/j.rmed.2019.105834Begrambekova Yu.L., Karanadze N.A., Orlova Ya.A. Alterations of the respiratory system in heart failure. Kardiologiia. 2019;59(2S):15–24. DOI: 10.18087/cardio.2626Frankenstein L, Nelles M, Meyer FJ, Sigg C, Schellberg D, Remppis BA et al. Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment. European Journal of Cardiovascular Prevention and Rehabilitation. 2009;16(4):424–9. DOI: 10.1097/HJR.0b013e3283030a7eHamazaki N, Kamiya K, Matsuzawa R, Nozaki K, Ichikawa T, Tanaka S et al. Prevalence and prognosis of respiratory muscle weakness in heart failure patients with preserved ejection fraction. Respiratory Medicine. 2020;161:105834. DOI: 10.1016/j.rmed.2019.105834Арутюнов А.Г., Ильина К.В., Арутюнов Г.П., Колесникова Е.А., Пчелин В.В., Кулагина Н.П. и др. Морфофункциональные особенности диафрагмы у больных с хронической сердечной недостаточностью. Кардиология. 2019;59(1):12-21. DOI: 10.18087/cardio.2019.1.2625Frankenstein L, Nelles M, Meyer FJ, Sigg C, Schellberg D, Remppis BA et al. Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment. European Journal of Cardiovascular Prevention and Rehabilitation. 2009;16(4):424–9. DOI: 10.1097/HJR.0b013e3283030a7eСоколова А.В., Драгунов Д.О., Арутюнов Г.П. Распространенность саркопении у пациентов с хронической сердечной недостаточностью и хронической болезнью почек. Клиническая нефрология. 2023;3:18-23. DOI: 10.18565/nephrology.2023.3.18-23Arutyunov A.G., Ilyina K.V., Arutyunov G.P., Kolesnikova E.A., Pchelin V.V., Kulagina N.P. et al. Morphofunctional Features of The Diaphragm in Patients With Chronic Heart Failure. Kardiologiia. 2019;59(1):12–21. DOI: 10.18087/cardio.2019.1.2625Yamada K, Kinugasa Y, Sota T, Miyagi M, Sugihara S, Kato M et al. Inspiratory Muscle Weakness Is Associated With Exercise Intolerance in Patients With Heart Failure With Preserved Ejection Fraction: A Preliminary Study. Journal of Cardiac Failure. 2016;22(1):38–47. DOI: 10.1016/j.cardfail.2015.10.010Sokolova A.V., Dragunov D.O., Arutyunov G.P. The prevalence of sarcopenia in patients with chronic heart failure and chronic kidney disease. Clinical Nephrology. 2023;3:18–23. DOI: 10.18565/nephrology.2023.3.18-23Thomsen RW, Kasatpibal N, Riis A, Nørgaard M, Sørensen HT. The Impact of Pre-existing Heart Failure on Pneumonia Prognosis: Population-based Cohort Study. Journal of General Internal Medicine. 2008;23(9):1407–13. DOI: 10.1007/s11606-008-0672-3Yamada K, Kinugasa Y, Sota T, Miyagi M, Sugihara S, Kato M et al. Inspiratory Muscle Weakness Is Associated With Exercise Intolerance in Patients With Heart Failure With Preserved Ejection Fraction: A Preliminary Study. Journal of Cardiac Failure. 2016;22(1):38–47. DOI: 10.1016/j.cardfail.2015.10.010Balmain BN, Tomlinson AR, MacNamara JP, Sarma S, Levine BD, Hynan LS et al. Physiological dead space during exercise in patients with heart failure with preserved ejection fraction. Journal of Applied Physiology. 2022;132(3):632–40. DOI: 10.1152/japplphysiol.00786.2021Thomsen RW, Kasatpibal N, Riis A, Nørgaard M, Sørensen HT. The Impact of Pre-existing Heart Failure on Pneumonia Prognosis: Population-based Cohort Study. Journal of General Internal Medicine. 2008;23(9):1407–13. DOI: 10.1007/s11606-008-0672-3Killian KJ, Jones NL. Respiratory muscles and dyspnea. Clinics in Chest Medicine. 1988;9(2):237–48. PMID: 3292125Balmain BN, Tomlinson AR, MacNamara JP, Sarma S, Levine BD, Hynan LS et al. Physiological dead space during exercise in patients with heart failure with preserved ejection fraction. Journal of Applied Physiology. 2022;132(3):632–40. DOI: 10.1152/japplphysiol.00786.2021Laveneziana P, Albuquerque A, Aliverti A, Babb T, Barreiro E, Dres M et al. ERS statement on respiratory muscle testing at rest and during exercise. European Respiratory Journal. 2019;53(6):1801214. DOI: 10.1183/13993003.01214-2018Killian KJ, Jones NL. Respiratory muscles and dyspnea. Clinics in Chest Medicine. 1988;9(2):237–48. PMID: 3292125Lee Y, Son S, Kim D-K, Park MW. Association of Diaphragm Thickness and Respiratory Muscle Strength With Indices of Sarcopenia. Annals of Rehabilitation Medicine. 2023;47(4):307–14. DOI: 10.5535/arm.23081Laveneziana P, Albuquerque A, Aliverti A, Babb T, Barreiro E, Dres M et al. ERS statement on respiratory muscle testing at rest and during exercise. European Respiratory Journal. 2019;53(6):1801214. DOI: 10.1183/13993003.01214-2018Mcelvaney G, Blackie S, Morrison NJ, Wilcox PG, Fairbarn MS, Pardy RI. Maximal Static Respiratory Pressures in the Normal Elderly. American Review of Respiratory Disease. 1989;139(1):277–81. DOI: 10.1164/ajrccm/139.1.277Lee Y, Son S, Kim D-K, Park MW. Association of Diaphragm Thickness and Respiratory Muscle Strength With Indices of Sarcopenia. Annals of Rehabilitation Medicine. 2023;47(4):307–14. DOI: 10.5535/arm.23081Polkey MI, Moxham J. Clinical Aspects of Respiratory Muscle Dysfunction in the Critically Ill. CHEST. 2001;119(3):926–39. DOI: 10.1378/chest.119.3.926Mcelvaney G, Blackie S, Morrison NJ, Wilcox PG, Fairbarn MS, Pardy RI. Maximal Static Respiratory Pressures in the Normal Elderly. American Review of Respiratory Disease. 1989;139(1):277–81. DOI: 10.1164/ajrccm/139.1.277Caruso P, Albuquerque ALPD, Santana PV, Cardenas LZ, Ferreira JG, Prina E et al. Diagnostic methods to assess inspiratory and expiratory muscle strength. Jornal Brasileiro de Pneumologia. 2015;41(2):110–23. DOI: 10.1590/S1806-37132015000004474Polkey MI, Moxham J. Clinical Aspects of Respiratory Muscle Dysfunction in the Critically Ill. CHEST. 2001;119(3):926–39. DOI: 10.1378/chest.119.3.926Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. The American Review of Respiratory Disease. 1969;99(5):696–702. DOI: 10.1164/arrd.1969.99.5.696Caruso P, Albuquerque ALPD, Santana PV, Cardenas LZ, Ferreira JG, Prina E et al. Diagnostic methods to assess inspiratory and expiratory muscle strength. Jornal Brasileiro de Pneumologia. 2015;41(2):110–23. DOI: 10.1590/S1806-37132015000004474Wilson SH, Cooke NT, Edwards RH, Spiro SG. Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax. 1984;39(7):535–8. DOI: 10.1136/thx.39.7.535Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. The American Review of Respiratory Disease. 1969;99(5):696–702. DOI: 10.1164/arrd.1969.99.5.696Enright PL, Kronmal RA, Manolio TA, Schenker MB, Hyatt RE. Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group. American Journal of Respiratory and Critical Care Medicine. 1994;149(2):430–8. DOI: 10.1164/ajrccm.149.2.8306041Wilson SH, Cooke NT, Edwards RH, Spiro SG. Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax. 1984;39(7):535–8. DOI: 10.1136/thx.39.7.535Hautmann H, Hefele S, Schotten K, Huber RM. Maximal inspiratory mouth pressures (PIMAX) in healthy subjects – what is the lower limit of normal? Respiratory Medicine. 2000;94(7):689–93. DOI: 10.1053/rmed.2000.0802Enright PL, Kronmal RA, Manolio TA, Schenker MB, Hyatt RE. Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group. American Journal of Respiratory and Critical Care Medicine. 1994;149(2):430–8. DOI: 10.1164/ajrccm.149.2.8306041Sachs MC, Enright PL, Hinckley Stukovsky KD, Jiang R, Barr RG, Multi-Ethnic Study of Atherosclerosis Lung Study. Performance of maximum inspiratory pressure tests and maximum inspiratory pressure reference equations for 4 race/ethnic groups. Respiratory Care. 2009;54(10):1321–8. PMID: 19796411Hautmann H, Hefele S, Schotten K, Huber RM. Maximal inspiratory mouth pressures (PIMAX) in healthy subjects – what is the lower limit of normal? Respiratory Medicine. 2000;94(7):689–93. DOI: 10.1053/rmed.2000.0802Sanchez FF, Araújo Da Silva CD, De Souza Pereira Gama Maciel MC, Rebouças Demósthenes Marques J, Brosina De Leon E, Lins Gonçalves R. Predictive equations for respiratory muscle strength by anthropometric variables. The Clinical Respiratory Journal. 2018;12(7):2292–9. DOI: 10.1111/crj.12908Sachs MC, Enright PL, Hinckley Stukovsky KD, Jiang R, Barr RG, MultiEthnic Study of Atherosclerosis Lung Study. Performance of maximum inspiratory pressure tests and maximum inspiratory pressure reference equations for 4 race/ethnic groups. Respiratory Care. 2009;54(10):1321–8. PMID: 19796411Moeliono M, Marta Sari D, Nashrulloh T. Prediction for the maximum inspiratory pressure value from the thoracic expansion measurement in Indonesian healthy young adults. Canadian Journal of Respiratory Therapy. 2022;58:34–8. DOI: 10.29390/cjrt-2021-064Sanchez FF, Araújo Da Silva CD, De Souza Pereira Gama Maciel MC, Rebouças Demósthenes Marques J, Brosina De Leon E, Lins Gonçalves R. Predictive equations for respiratory muscle strength by anthropometric variables. The Clinical Respiratory Journal. 2018;12(7):2292–9. DOI: 10.1111/crj.12908Лелявина Т.А., Ситникова М.Ю., Галенко В.Л., Борцова М.А. Неинвазивный способ выявления изменения содержания молочной кислоты в крови больных хронической сердечной недостаточностью при помощи протокола тредмил-теста с непрерывно возрастающей физической нагрузкой. Патент на изобретение RU 2789272 C1 от 31.01.2023. Заявка №2022102976А от 07.02.2022. Доступно на: https://patents.google.com/patent/RU2789272C1/ruMoeliono M, Marta Sari D, Nashrulloh T. Prediction for the maximum inspiratory pressure value from the thoracic expansion measurement in Indonesian healthy young adults. Canadian Journal of Respiratory Therapy. 2022;58:34–8. DOI: 10.29390/cjrt-2021-064Лелявина Т.А., Ситникова М.Ю. Способ определения биологических резервов адаптации организма к физической нагрузке. Патент на изобретение RU 2574901 C1 от 10.02.2016. Заявка № 2014139641/15 от 30.09.2014. Доступно на: https://patenton.ru/patent/RU2574901C1?ysclid=lyjr58qcrc422915792Lelyavina T.A., Sitnikova M.Yu., Galenko V.L., Bortsova M.A. Non-invasive method for detecting changes in the lactic acid content in the blood of patients with chronic heart failure using the treadmill test protocol with continuously increasing physical activity. Patent for the invention RU 2789272 C1 from 31.01.2023. Application No.2022102976A from 07.02.2022. Av. at: https://patents.google.com/patent/RU2789272C1/ru.Lelyavina T.A., Sitnikova M.Yu. Method for determining the biological reserves of the body’s adaptation to physical activity. Patent for the invention RU 2574901 C1 from 10.02.2016. Application No. 2014139641/15 from 30.09.2014. Av. at: https://patenton.ru/patent/RU2574901C1?ysclid=lyjr58qcrc422915792.Lelyavina T.A., Sitnikova M.Yu. Method for determining the biological reserves of the body’s adaptation to physical activity. Patent for the invention RU 2574901 C1 from 10.02.2016. Application No. 2014139641/15 from 30.09.2014. Av. at: https://patenton.ru/patent/RU2574901C1?ysclid=lyjr58qcrc422915792.

The authors declare that there are no conflicts of interest present.